cellvie Alternatives & Competitors
12 companies similar to cellvie — Levearging the therapeutic potential of mitochondria
Companies similar to cellvie
HepaTx Corporation
Off-the-shelf cell therapies for liver disease
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
Aspen Neuroscience, Inc.
Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...
BridgeBio
We move at the speed of patient need.
Rival Readout
Competing with cellvie? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Aspect Biosystems
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusi...
Endogena Therapeutics, Inc.
endogena’s mission is to discover and develop endogenous regenerative medicines to repair...
Nephrogen
Curative gene therapies for kidney diseases
Q Therapeutics
Q has developed a human cell based therapeutic product to treat degenerative disorders of...
Angiocrine Bioscience, Inc.
Transforming medicine through engineered cellular therapies that restore, regenerate, and...
Poseida Therapeutics, Inc.
A Member of the Roche Group
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
THRASOS LIMITED
Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on k...
About cellvie
cellvie, founded in 2018, is at the forefront of an innovative healthcare approach known as Therapeutic Mitochondria Transplantation (TMT), aiming to harness the potential of mitochondria for medical treatments. Originating from research developed by Dr. James McCully at Harvard Medical School, this Swiss-based startup...
Mitochondrial Augmentation, Cellular Energy Recovery, Medical Research and Development, Ischemia-Reperfusion Treatment
Healthcare Providers, Organ Transplant Centers, Patients with Ischemia-Reperfusion Conditions, Aging Population with Degenerative Conditions
Therapeutic Mitochondria Transplantation, Mitochondria Augmentation, Mitochondria Replacement, Cell-Derived Medicines, Ischemia-Reperfusion Injury, Solid Organ Transplantation, Cellular Energy, Mitochondria Function, Acute Conditions, Genetic Disorders, Mitochondria Research, Medical Innovation, Cellular Therapies, Regenerative Medicine
B2B, B2D
Licensing, Service Fee, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around cellvie: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at cellvie on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.